1
|
Energy metabolism
|
00190
|
Oxidative phosphorylation
|
11
|
1
|
10
|
2
|
Carbohydrate metabolism
|
01200
|
Carbon metabolism
|
8
|
2
|
6
|
00030
|
Pentose phosphate pathway
|
4
|
0
|
4
|
00040
|
Pentose and glucuronate interconversions
|
4
|
1
|
3
|
00051
|
Fructose and mannose metabolism
|
4
|
1
|
3
|
00010
|
Glycolysis / Gluconeogenesis
|
3
|
0
|
3
|
00052
|
Galactose metabolism
|
2
|
1
|
1
|
00520
|
Amino sugar and nucleotide sugar metabolism
|
2
|
1
|
1
|
00620
|
Pyruvate metabolism
|
2
|
1
|
1
|
00630
|
Glyoxylate and dicarboxylate metabolism
|
2
|
1
|
1
|
3
|
Amino acid metabolism
|
01230
|
Biosynthesis of amino acids
|
5
|
1
|
4
|
00260
|
Glycine, serin vitamin e and threonine metabolism
|
5
|
1
|
4
|
00340
|
Histidine metabolism
|
5
|
0
|
5
|
00350
|
Tyrosine metabolism
|
3
|
0
|
3
|
00250
|
Alanine, aspartate and glutamate metabolism
|
3
|
1
|
2
|
00270
|
Cysteine and methionine metabolism
|
3
|
0
|
3
|
00220
|
Arginine biosynthesis
|
2
|
0
|
2
|
4
|
Lipid metabolism
|
00590
|
Arachidonic acid metabolism
|
2
|
0
|
2
|
00561
|
Glycerolipid metabolism
|
2
|
1
|
1
|
00140
|
Steroid hormone biosynthesis
|
2
|
0
|
2
|
5
|
Metabolism of cofactors and vitamins
|
00790
|
Folate biosynthesis
|
4
|
1
|
3
|
00760
|
Nicotinate and nicotinamide metabolism
|
2
|
1
|
1
|
00830
|
Retinol metabolism
|
2
|
0
|
2
|
6
|
Xenobiotics biodegradation and metabolism
|
00982
|
Drug metabolism - cytochrome P450
|
3
|
1
|
2
|
00980
|
Metabolism of xenobiotics by cytochrome P450
|
3
|
0
|
3
|
00983
|
Drug metabolism - other enzymes
|
2
|
0
|
2
|
7
|
Nucleotide metabolism
|
00240
|
Pyrimidine metabolism
|
2
|
0
|
2
|
8
|
Signal transduction
|
04020
|
Calcium signaling pathway
|
5
|
1
|
4
|
04152
|
AMPK signaling pathway
|
3
|
0
|
2
|
04151
|
PI3K-Akt signaling pathway
|
2
|
1
|
1
|
9
|
Nervous system
|
04723
|
Retrograde endocannabinoid signaling
|
10
|
0
|
10
|
10
|
Neurodegenerative diseases
|
05012
|
Parkinson’s disease
|
11
|
1
|
10
|
05016
|
Huntington’s disease
|
11
|
1
|
10
|
05010
|
Alzheimer’s disease
|
10
|
0
|
10
|
11
|
Endocrine system
|
04910
|
Insulin signaling pathway
|
6
|
0
|
6
|
04922
|
Glucagon signaling pathway
|
5
|
0
|
5
|
12
|
Endocrine and metabolic diseases
|
04932
|
Non-alcoholic fatty liver disease (NAFLD)
|
10
|
0
|
10
|
13
|
Transport and catabolism
|
04142
|
Lysosome
|
5
|
5
|
0
|
04144
|
Endocytosis
|
2
|
0
|
2
|
04145
|
Phagosome
|
2
|
2
|
0
|
14
|
Cancers
|
05204
|
Chemical carcinogenesis
|
3
|
0
|
3
|
05205
|
Proteoglycans in cancer
|
2
|
1
|
1
|
05200
|
Pathways in cancer
|
2
|
0
|
2
|
15
|
Cell growth and death
|
04114
|
Oocyte meiosis
|
2
|
1
|
1
|
04110
|
Cell cycle
|
2
|
1
|
1
|
04217
|
Necroptosis
|
2
|
2
|
0
|
16
|
Cell motility
|
04810
|
Regulation of actin cytoskeleton
|
2
|
1
|
1
|
17
|
Immune system
|
04612
|
Antigen processing and presentation
|
2
|
2
|
0
|
04621
|
NOD-like receptor signaling pathway
|
2
|
2
|
0
|
04610
|
Complement and coagulation cascades
|
2
|
2
|
0
|
18
|
Infectious diseases
|
05120
|
Epithelial cell signaling in Helicobacter pylori infection
|
2
|
1
|
1
|
19
|
Digestive system
|
04976
|
Bile secretion
|
2
|
0
|
2
|
20
|
Excretory system
|
04966
|
Collecting duct acid secretion
|
2
|
1
|
1
|